Trials / Conditions / Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Recurrent
Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Recurrent
5 registered clinical trials studyying Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Recurrent — 4 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | HEM-iSMART E: Capivasertib + Venetoclax + Dexamethasone in Pediatric Patients With Relapsed or Refractory Hema NCT07175415 | Princess Maxima Center for Pediatric Oncology | Phase 1 / Phase 2 |
| Recruiting | HEM-iSMART-C: Ruxolitinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients NCT05745714 | Princess Maxima Center for Pediatric Oncology | Phase 1 / Phase 2 |
| Recruiting | HEM-iSMART-B: Dasatinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients W NCT05751044 | Princess Maxima Center for Pediatric Oncology | Phase 1 / Phase 2 |
| Recruiting | HEM iSMART-D: Trametinib + Dexamethasone + Chemotherapy in Children With Relapsed or Refractory Hematological NCT05658640 | Princess Maxima Center for Pediatric Oncology | Phase 1 / Phase 2 |
| Withdrawn | HEM-iSMART-A: Decitabine / Venetoclax and Navitoclax in Pediatric Patients With Relapsed or Refractory Hematol NCT05740449 | Princess Maxima Center for Pediatric Oncology | Phase 1 / Phase 2 |